Mounjaro®
Starting from £179.99/mo
Start journey Learn moreUK private Wegovy treatment is priced per pen, and because the dose you take changes over the course of treatment, so does the monthly cost. NICE's appraisal of semaglutide for weight management confirms that the licensed maintenance dose for most adults is 2.4mg weekly, reached through a gradual titration that starts at 0.25mg — meaning early months typically cost less than later ones. These are prescription-only medicines: a clinician assesses your suitability before any dose or prescription is issued, and the amount you take is determined by your prescriber, not by you or the cheapest listing you can find online.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The NICE appraisal of semaglutide for weight management (TA875) describes a stepped titration: the treatment begins at 0.25mg weekly and increases roughly every four weeks through 0.5mg, 1.0mg and 1.7mg before reaching the 2.4mg maintenance dose. In January 2026 the MHRA also approved a higher 7.2mg dose for eligible adults with a BMI of 30 or above, initially delivered as three 2.4mg pens weekly and later as a dedicated single-dose pen approved in April 2026. The STEP 1 trial, published in the New England Journal of Medicine, found an average weight reduction of around 15% over 68 weeks at 2.4mg.
This phased structure is clinically deliberate: starting low reduces the likelihood of nausea and other gastrointestinal side effects, and the prescriber decides whether to increase, hold or slow the progression. What this means practically is that a patient in month one is on a lower-dose pen than a patient in month five. If you are trying to understand how much semaglutide to take for weight loss, the dose is not yours to choose, which is exactly why that question belongs in a consultation, not a product listing.
For a fuller look at the dosing schedule itself, our prescribers explain it in detail on the page covering how much semaglutide to take.
UK private semaglutide (Wegovy) prices are quoted per pen, and pens correspond to dose strengths, so a lower-dose starter pen and a 2.4mg maintenance pen are rarely the same price. Since Eli Lilly's well-reported August 2025 list-price change for Mounjaro, market-wide attention to GLP-1 pricing has intensified, and some providers have restructured their Wegovy pricing similarly. If you are researching the cheapest site for Wegovy, reported private prices have ranged broadly by dose and provider, and our Wegovy price page gives more context on current market ranges.
What a headline monthly figure often excludes is worth checking carefully: consultation fees, prescription charges and dispensing fees are sometimes added at checkout. Delivery, which may seem trivial, can reach £10–£15 per order with some providers. Dose-review support (the clinical check before your prescriber issues a higher-dose prescription) is sometimes listed as a separate fee. If you're comparing quotes, the honest test is the total cost of a complete month's treatment, not the pen price alone.
There is also the question of genuine supply chain. The MHRA's Drug Safety Update communications have repeatedly flagged counterfeit weight-loss pens circulating online. Prices far below market, sellers without a verifiable GPhC registration, or promotions offering these medicines without a clinical assessment are meaningful red flags, not bargains.
At nume, one price covers the consultation, the prescription, the treatment, and free next-working-day delivery via DPD) tracked, in a plain unbranded box, nothing announcing what's inside. There are no add-on fees and no subscription. Every repeat order goes back to a GPhC-registered prescriber for clinical review; the price of that review is not billed separately.
We are not the cheapest provider. That is a deliberate choice. A GPhC-registered online pharmacy with same-day clinical review, ID and live weight verification, and seven-day aftercare costs more to run than an automated sign-up form. The current treatment pricing is shown on our treatment page; we don't print per-pen prices in articles because the right price for you depends on which dose your prescriber determines is appropriate.
You can verify nume, sorry, you can verify nume on the GPhC register under premises number 9012878. That check takes about thirty seconds and is the single most useful thing to do before handing over a prescription to any online pharmacy.
Price is not the wrong thing to think about. It is the wrong thing to optimise for. A prescription medicine dispensed after a genuine clinical assessment, from an MHRA-regulated pharmacy stocked through the licensed UK supply chain, is not the same product as an identical-looking pen bought from a social media seller at half the price. The MHRA has seized large quantities of fake weight-loss pens since its first major counterfeit warning in 2023, some contained insulin rather than semaglutide.
The useful questions are: does this provider check that I am clinically suitable? Does a named prescriber review my information? Can I verify the pharmacy on the GPhC register? Is the supply chain traceable? Cost matters when you're comparing providers who all answer yes to those questions. It is a secondary consideration, not the lead one.
If you want to understand how the dose your prescriber recommends connects to what you inject each week, this page walks through the injection specifics. For broader context on semaglutide pricing across providers, our Ozempic semaglutide injection price guide sets out the market honestly. And if you'd like to discuss your situation with our clinical team, our lead prescriber's profile gives a sense of who reviews every consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.